×
About 648 results

ALLMedicine™ Hallucinogens Center

Research & Reviews  217 results

Psilocybin-facilitated Treatment for Chronic Pain
https://clinicaltrials.gov/ct2/show/NCT05068791

Jan 13th, 2022 - Participants will be randomized to two groups: Psilocybin or Active Placebo. Those in the Psilocybin condition will receive .36 mg/kg of psilocybin. Based on previous research, .36 mg/kg of psilocybin is expected to balance the intention to increa...

A systematic literature review of clinical trials and therapeutic applications of iboga...
https://doi.org/10.1016/j.jsat.2021.108717
Journal of Substance Abuse Treatment; Köck P, Frölich K et. al.

Jan 12th, 2022 - Iboga and its primary alkaloids, ibogaine and noribogaine, have been of interest to researchers and practitioners, mainly due to their putative efficacy in treating substance use disorders (SUDs). For many SUDs, still no effective pharmacotherapie...

Characterization of the discriminative stimulus effect of quinpirole: Further evidence ...
https://doi.org/10.1016/j.pbb.2021.173314
Pharmacology, Biochemistry, and Behavior; Mori T, Yamashita K et. al.

Dec 18th, 2021 - Dysfunction of the central dopamine D2-receptor-related network has been proposed to play a critical role in dopamine-related diseases, such as schizophrenia and drug dependence. Generally, the stimulation of dopamine D2-receptors on medium spiny ...

Hallucinogen Use and Misuse in Older Adults.
https://doi.org/10.1016/j.cger.2021.07.007
Clinics in Geriatric Medicine; Redden WM, Paracha SU et. al.

Nov 20th, 2021 - Hallucinogens, or psychedelics, are substances/drugs that have been used for over a millennium. The most well known are LSD, psilocybin, mescaline, and PCP. These substances may induce hallucinations as well as cause somatic and psychological symp...

Cocaine-Related Psychiatric Disorders
https://emedicine.medscape.com/article/290195-print

Nov 18th, 2021 - Background Cocaine is a naturally occurring alkaloid found within the leaves of a shrub, Erythroxylon coca. The earliest reported use of cocaine dates back to times when the ancient inhabitants of Peru used the leaves for religious ceremonies. Coc...

see more →

Clinicaltrials.gov  3 results

Psilocybin-facilitated Treatment for Chronic Pain
https://clinicaltrials.gov/ct2/show/NCT05068791

Jan 13th, 2022 - Participants will be randomized to two groups: Psilocybin or Active Placebo. Those in the Psilocybin condition will receive .36 mg/kg of psilocybin. Based on previous research, .36 mg/kg of psilocybin is expected to balance the intention to increa...

Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
https://clinicaltrials.gov/ct2/show/NCT01943994

Oct 4th, 2021 - One of the most promising lines of investigation for the therapeutic use of hallucinogens in the 1960s and 1970s was in the treatment of drug dependence. The investigators propose to examine psilocybin administration combined with a structured smo...

Comparative Acute Effects of LSD, Psilocybin and Mescaline
https://clinicaltrials.gov/ct2/show/NCT04227756

Sep 8th, 2021 - LSD (lysergic acid diethylamide), psilocybin (the active substance in "magic mushrooms") and mescaline (the active substance in Peyote and San Pedro cacti) are serotonergic hallucinogens widely used for recreational and/or ethnomedical purposes. L...

see more →

News  38 results

A Pandemic Silver Lining? Dramatic Drop in Teen Drug Use
https://www.medscape.com/viewarticle/964881

Dec 15th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Illicit drug use among US teenagers dropped sharply in 2021 likely because of stay-at-home orders and other restrictions on social activities due ...

Marijuana and Hallucinogen Use on the Rise in Young People
https://www.medscape.com/viewarticle/959888

Sep 28th, 2021 - Young adults appear to be turning away from alcohol and toward marijuana and hallucinogens, according to a survey on national drug use trends. What to know: In 2020, marijuana use continued its recent increase among young adults. Hallucinogens lik...

An International Trip: Global Experts Weigh In on Psychedelics
https://www.medscape.com/viewarticle/948483

Mar 31st, 2021 - In 1967, when the United Nations Convention on Drugs classified psychedelics as Schedule I substances, it effectively ended research into these agents as potential therapeutics for psychiatric disorders. Psychedelics induce altered states of perce...

Evidence Mounts for Psilocybin as Depression Tx
https://www.medpagetoday.com/psychiatry/depression/89484

Nov 4th, 2020 - Synthetic psilocybin reduced depression severity for patients with major depressive disorder (MDD) when administered with standard psychotherapy, a randomized clinical trial found. Among 24 patients with MDD, psilocybin plus psychotherapy was asso...

Visual Snow Is Real
https://www.medpagetoday.com/neurology/generalneurology/84531

Jan 24th, 2020 - Visual snow syndrome (VSS) -- a disorder in which patients experience persistent tiny flickering dots that resemble analog television static in their visual field -- likely represents a clinical continuum with different degrees of severity, a larg...

see more →

Patient Education  1 results see all →